Stifel Financial has agreed to buy Bryan, Garnier & Co., a leading independent full-service investment bank focused on European technology and healthcare companies. The terms of the deal were undisclosed.
Founded in 1996, Bryan Garnier’s product suite features mergers & acquisitions advisory, private and public growth financing solutions, and institutional sales & execution. And with a team of about 200 professionals, including 33 Managing Directors, Bryan Garnier is headquartered in Paris and has offices in London, Amsterdam, Munich, Oslo, Stockholm, and New York.
Stifel has grown organically and through acquisition over the year and is on pace to generate over $4.8 billion in net revenue in 2024. And with nearly 10,000 professionals located across about 400 offices across the United States, Europe, the Middle East, and Asia, Stifel is a leading M&A advisor and a premier capital markets firm.
Keefe, Bruyette & Woods, a Stifel Company acted as exclusive financial advisor and Bryan Cave Leighton Paisner acted as legal advisor to Stifel in the transaction. And Houlihan Lokey acted as exclusive financial advisor and White & Case acted as legal advisor to Bryan Garnier.
KEY QUOTES:
“As a leading European middle market investment bank in the healthcare and technology verticals, Bryan Garnier represents an ideal partner. Its culture and long-term history of providing clients with high quality advice in two of our largest investment banking growth verticals is highly complementary with Stifel’s business. This combination is a logical next step in the evolution of Stifel’s global advisory business.”
– Ronald J. Kruszewski, Stifel Chairman and CEO
“By integrating Stifel’s capabilities across advisory, private and public markets, and equity and debt solutions, Stifel and Bryan Garnier are offering unparalleled opportunities for clients, employees, and the European market as a whole.”
– Olivier Garnier, co-founder and Managing Partner of Bryan Garnier
